PSA指數升高為初始表現的攝護腺神經鞘瘤
賴宗豪1、林克勳1、許軒豪1
1臺北市立萬芳醫院 泌尿科
Schwannoma of the prostate presenting with elevated PSA level
Chung-Howe Lai1, Ke-Hsun Lin1, Syuan-Hao Syu1
1Department of Urology, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan
 
Abstract:
Schwannomas are rare tumors originated from the schwann cell of the peripheral nerve sheaths, generally occurring in young and middle-aged adults, and sometimes related to inheritable disorders, such as neurofibromatosis type 1. The most common locations include head, neck, extremities, mediastinum and retroperitoneum but very rarely the male genital system. Herein, we report a case of a 65-year-old man who was thought to be either a benign prostate hyperplasia (BPH) or prostate cancer patient, initially presented with elevated PSA level (up to 12ng/ml). Lower urinary tract symptoms (LUTS) were mild. Digital rectal examination revealed a grade 3 enlarged prostate with a palpable left side hard nodule. Transrectal ultrasonography (TRUS) revealed estimated prostate volume 61.2cm3 and a hypoechoic nodule over left lateral lobe. Biopsy revealed a spindle cell tumor with alternating cellularity, and immunohistochemically positive for S-100, validating a schwannoma of the prostate. BPH but no cancer was found in all other biopsied sections. Magnetic resonance imaging confirmed the mass in the prostate and showed no evidence of local extension or other lesions elsewhere. Due to mild symptoms presentation, the patient was not operated on. Neither tumor enlargement, further elevated PSA nor worsening of LUTS were found during a total follow up period of 6 years up to date. Despite previous literature often suggesting surgery for these rare tumors, active surveillance seems to be a feasible treatment choice for patients with a schwannoma of the prostate without bothersome symptoms.
    位置
    資料夾名稱
    摘要
    發表人
    TUA秘書處
    單位
    台灣泌尿科醫學會
    建立
    2019-07-12 15:59:45
    最近修訂
    2019-07-12 16:05:56
    更多